Evidence map›Paper›PMID 27590306›Full record

ArticleCancer causes & control : CCC2016

The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database.

Anna B Beckmeyer-Borowko, Caryn E Peterson, Katherine C Brewer, Mary A Otoo, Faith G Davis, Kent F Hoskins, Charlotte E Joslin

Abstract read
In one paragraph

Article in Cancer causes & control : CCC, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Mechanistic Insights intoInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Anna B Beckmeyer-BorowkoDepartment of Epidemiology and Biostatistics, University of Illinois at Chicago, 1603 W. Taylor Ave., Chicago, IL, 60612, USA.ORCID 0000-0003-1447-7419
Caryn E PetersonDepartment of Epidemiology and Biostatistics, University of Illinois at Chicago, 1603 W. Taylor Ave., Chicago, IL, 60612, USA.
Katherine C BrewerDepartment of Epidemiology and Biostatistics, University of Illinois at Chicago, 1603 W. Taylor Ave., Chicago, IL, 60612, USA.
Mary A OtooDepartment of Epidemiology and Biostatistics, University of Illinois at Chicago, 1603 W. Taylor Ave., Chicago, IL, 60612, USA.
Faith G Davis3-317 Edmonton Clinic Health Academy, University of Alberta School of Public Health, 11405 87 Avenue, Edmonton, AB, T6G 1C9, Canada.
Kent F HoskinsCancer Control and Population Science Research Program, University of Illinois at Chicago Cancer Center, 1855 W. Taylor St, Ste.3.154, Chicago, IL, 60612, USA.
Charlotte E JoslinDepartment of Epidemiology and Biostatistics, University of Illinois at Chicago, 1603 W. Taylor Ave., Chicago, IL, 60612, USA. charjosl@uic.edu.
University of Illinois Chicago · USRoosevelt University · USUniversity of Alberta · CA

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MCANANY, JAMES JASON · 1985 to 2025
$14.8M
Research Education CoreU54CA202997 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NAYLOR, KEITH BRIAN, TUSSING-HUMPHREYS, LISA · 2015 to 2024
$13.8M
The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)U54CA202995 · NCI · NORTHEASTERN ILLINOIS UNIVERSITY · PI CIECIERSKI, CHRISTINA · 2015 to 2024
$9.5M
UIC CANCER PREVENTION &CONTROL RESEARCH TRAINING GRANTR25CA057699 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FITZGIBBON, MARIAN L. · 1992 to 2017
$8.2M
NCI NIH HHS R25 CA057699NCI NIH HHS U54 CA202995NCI NIH HHS U54 CA202997NEI NIH HHS P30 EY001792
6 · The paper itself

Abstract

purposePrevious studies assessing racial and ethnic differences in ovarian cancer (OVCA) diagnosis stage fail to present subtype-specific results and provide historic data on cases diagnosed between 10 and 20 years ago. The purpose of this analysis is to assess non-Hispanic Black (NHB) and non-Hispanic White (NHW) differences in late-stage diagnosis including; (1) factors associated with late-stage diagnosis of invasive epithelial OVCA overall and by histologic subtypes, (2) potential changes across time and (3) current patterns of trends in a national cancer registry in the USA and Puerto Rico between 1998 and 2011.

methodsNHB and NHW OVCA cases were derived from the National Cancer Database (NCDB). Diagnosis stage was analyzed as a dichotomous and a four level-category variable, respectively; early (stages I and II; localized) versus late (stages III and IV; regional and distant) and stages I, II, III and IV. Diagnosis period was trichotomized (1998-2002, 2003-2007, 2008-2011). Racial differences in stage were tested using Chi-square statistics. Odds ratios (OR) and 95 % confidence intervals (95 % CI) were estimated using multivariable binomial and generalized ordered logistic regressions. Interactions between race and diagnosis period were evaluated.

resultsBetween 1998 and 2011, 11,562 (7.8 %) NHB and 137,106 (92.2 %) NHW were diagnosed with OVCA. In adjusted models, NHB were significantly more likely diagnosed with late-stage OVCA than NHW (ORadj 1.26, 95 % CI 1.19-1.33). Interaction between race and diagnosis period was marginally significant (p value = 0.09), with racial differences in stage decreasing over time (1998-2002: ORadj 1.36, 95 % CI 1.23-1.49; 2003-2007: ORadj 1.27, 95 % CI 1.15-1.39; 2008-2011; ORadj 1.15, 95 % CI 1.05-1.27). NHB were also more likely to be diagnosed with stage 4 high-grade serous (ORadj 1.46, 95 % CI 1.22-1.74), clear cell (ORadj 2.71, 95 % CI 1.94-3.79) and mucinous (ORadj 2.78, 95 % CI 2.24-3.46) carcinomas than NHW.

conclusionsRacial differences in late-stage OVCA diagnosis exist; however, these differences are decreasing with time. Within NCDB, NHB are significantly more likely diagnosed with late-stage OVCA and more specifically high-grade serous, clear cell and mucinous carcinomas than NHW.

Indexed as

AgedBlack or African AmericanCarcinoma, Ovarian EpithelialFemaleHispanic or LatinoHumansMiddle AgedNeoplasms, Glandular and EpithelialNeoplasm StagingOvarian NeoplasmsPuerto RicoSocioeconomic FactorsUnited StatesWhite PeopleDiagnosis stageHigh-grade serousNon-Hispanic BlackNon-Hispanic WhiteOvarian cancerRacial differencesRacial disparitiesTime-trend

Identifiers

PMID27590306
PMCPMC5418550
OpenAlexW2511267411

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.